Αρχική World News Radiation-Induced ‘Genomic Scars’ Associate with Poor Patient Outcome

Radiation-Induced ‘Genomic Scars’ Associate with Poor Patient Outcome

Radiotherapy of diffuse gliomas results in an increased number of genomic small deletions that make up a unique signature, according to findings presented at the MAP 2020 Virtual Congress. Furthermore, an increased burden of radiation-induced deletions was significantly associated with poorer patient outcome.

Emre Kocakavuk of the Jackson Laboratory for Genomic Medicine in Farmington, USA headed a research team that endevoured to determine the genomic effects of radiation therapy, which remain unknown. In contrast, it is known that alkylating chemotherapy can drive tumours to develop a hypermutator phenotype.

The investigators analysed the mutational spectra following treatment with ionizing radiation in sequencing data from 190 paired primary and recurrent gliomas from the Glioma Longitudinal Analysis (GLASS) dataset and 2116 post-treatment metastatic tumours from the Hartwig Medical Foundation.

A significant increase in the burden of small deletions was identified after radiation therapy that was independent of other factors. These novel deletions demonstrated distinct characteristics when compared with pre-existing deletions present prior to radiation therapy and also compared with deletions in radiation-untreated tumours.

In comparison, the radiation therapy-acquired deletions characteristically had a larger deletion size; the GLASS cohort (p = 1.2e-02) and the metastatic cohort (p < 2e-16 by Mann-Whitney U test), and an increased distance to repetitive DNA elements (p < 2e-16, by Kolmogorov-Smirnov test). A reduction in microhomology at breakpoints (p = 3.2e-02, paired Wilcoxon signed-rank test) was also detected.

The investigators explained that these observations suggested that canonical non-homologous end joining (c-NHEJ) was the preferred pathway for DNA double-strand break repair of radiation therapy-induced DNA damage. In addition, radiotherapy resulted in frequent chromosomal deletions and significantly increased frequencies of CDKN2A homozygous deletions in IDH-mutant gliomas.

Importantly, a high burden of radiation therapy-associated deletions was found to associate with poorer clinical outcomes; GLASS cohort (p < 1e-04), and metastatic cohort (p = 2.6e-02, by Wald test).

Radiation-Induced-Genomic-Scars-Associate-with-Poor-Patient-Outcome

Graphical abstract of the work ‘Radiotherapy in cancer is associated with a deletion signature that contributes to poor survival’. Created with BioRender.com

© Emre Kocakavuk.

Conclusions

According to the authors, these findings suggest that effective repair of radiation therapy-induced DNA damage is detrimental to patient survival. They further suggest that inhibiting c-NHEJ may be a viable strategy for improving the anti-tumour effect of radiotherapy.

Taken together, the identified genomic scars resulting from radiation therapy reflect a more aggressive tumour with increased levels of resistance to subsequnt treatments.

This work was supported by multiple grants.

Reference

2MO – Kocakavuk E, Anderson KJ, Johnson KC, et al. Radiotherapy in cancer is associated with a deletion signature that contributes to poor patient outcomes. MAP 2020 Virtual Congress (9-10 October 2020).

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...